Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-25T06:30:27.328Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical treatment of obesity: are drugs and surgery the answer?

Published online by Cambridge University Press:  07 March 2007

Peter G. Kopelman
Peter G. Kopelman
Affiliation:
Barts and the London, Queen Mary's School of Medicine & Dentistry, University of London, Turner Street, London E1 2AD, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Obesity treatment remains a ‘Cinderella’ of all clinical management programmes, but generally without a happy ending. The great expectation for new therapeutic agents has not been fulfilled in clinical practice, whilst the restriction of eating through surgical division of the upper bowel seems strange in an age of advanced and sophisticated technology. The better understanding of the neuro-regulation of appetite, and its application as part of evidence-based clinical interventions, could lead to a more coherent approach to obesity treatment. Nevertheless, investigation of potential neuroendocrine targets for appetite suppression suggests redundancy in the systems, which make development of effective agents against single receptors impractical. Importantly, the progressive rise in the prevalence of obesity will inevitably mean that only a small proportion of afflicted patients will actually be treated by long-term drugs and surgery. Drugs and surgery are not currently the answer for the majority of obese individuals. What is required is a better way of identifying patients who may particularly benefit from such approaches. However, the major emphasis must be the development of effective population-wide interventions that halt the increase in fatness and ensure that future generations maintain and enjoy a healthy body weight.

Keywords

ObesityAnti-obesity drugsObesity surgery
Type
Plenary Lecture
Information
Proceedings of the Nutrition Society , Volume 64 , Issue 1 , February 2005 , pp. 65 - 71
Copyright
Copyright © The Nutrition Society 2005

References

Ahima, RS & Osei, SY (2002) Neuroendocrine regulation of appetite and energy balance. Current Opinion in Endocrinology and Diabetes 9, 215–223 Google Scholar
Calam, J (2003) Peptic ulcer disease. In Oxford Textbook of Medicine, pp. 4th ed 558–568 [Warrell, DA, Cox, TM, Firth, JD, editors]. Oxford: Oxford University Press.Google Scholar
Chief Medical Officer (2002) The Annual Report of the Chief Medical Officer 2002. London: Department of Health.Google Scholar
Considine, RV, Sinha, MK, Heiman, ML, Kriauciunas, A, Stephens, TW, Nyce, MR et al. (1996) Serum immunoreactive-leptin concentrations in normal weight and obese humans. New England Journal of Medicine 334, 292–295 CrossRefGoogle ScholarPubMed
Department of HealthDepartment of Health (2003) Health Survey for England, 2002 London The Stationery Office www.doh.gov.uk/stats/trends1.htm Google Scholar
Farooqi, LS, Matarese, G, Lord, GM, Keogh, JM, Lawrence, E, Agwu, C et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 8, 1093–1103 Google Scholar
Gortmaker, SL, Must, A, Sobol, AM, Peterson, K, Colditz, GA & Dietz, WH (1996) Television viewing as a cause of increasing obesity among children in the United States. Archives of Pediatrics and Adolescent Medicine 150, 356–362 Google Scholar
Hansson, L, Lindholm, LH, Ekborn, T, Dahlof, B, Lanke, J, Schersten, B, Wester, PO, Hedner, T & de Faire, U (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish Trial in old patients with Hypertension-2 Study. Lancet 354, 1751–1756 Google Scholar
Heymsfield, SB, Grenberg, AS, Fujioka, K, Dixon, RM, Kushner, R, Hunt, T, Lubina, JA, Patane, J, Self, B, Hunt, P & McCamish, M (1999) Recombinant leptin for weight loss in obese and lean adults. Journal of the American Medical Association 282, 1568–1575 Google Scholar
House of, Commons Health Committee (2004) Obesity. Third Report of Session 2003–04. London: The Stationery Office.Google Scholar
Kesaniemi, YA, Danforth, E, Jensen, MD, Kopelman, PG, Lefebvre, P & Reeder, BA (2001) Dose-response issues concerning physical activity and health: an evidence-based symposium. Medicine and Science in Sports and Exercise 33, S351–S358 Suppl.Google Scholar
Knowler, WC, Barett-Connor, PH, Fowler, SE, Hamman, RF, Lechin, PH, Walker, EA & Nathan, DM (2002) Reduction in the incidence of type 2 diabetes mellitus by changes in lifestyle intervention or metformin. Diabetes Prevention Program Research Group. New England Journal of Medicine 346, 393–403 Google ScholarPubMed
Kopelman, PG (2000) Obesity as a medical problem. Nature 404, 635–643 Google Scholar
Kopelman, PG & Grace, C (2004) New thoughts on managing obesity. Gut 53, 1044–1053 Google Scholar
Kral, JG (1996) Side effects, complications and problems in anti-obesity surgery: introduction of the obesity severity index. In Progress in Obesity Research, pp. Vol. 7 655–661 [Angel, A, Anderson, K, Bouchard, C, editors]. London: John Libbey & Co. Ltd.Google Scholar
Lew, EA (1985) Mortality and weight: insured lives and the American Cancer Study. Annals of Internal Medicine 103, 1024–1029 Google Scholar
Lobstein, TJ, James, WP & Cole, TJ (2003) Increasing levels of excess weight among children in England. International Journal of Obesity 27, 1136–1138 Google Scholar
Montague, CT, Farooqi, IS, Whitehead, JP, Soos, MA, Rau, H, Wareham, NJ et al. (1997) Congenital leptin deficiency is associated with severe early onset obesity in humans. Nature 387, 903–909 CrossRefGoogle ScholarPubMed
National Audit Office (2001) Tackling Obesity in England. Report by the Comptroller and Auditor General Norwich: UK National Audit OfficeGoogle Scholar
National Institute, for Clinical Excellence (2001) Guidance on the Use of Orlistat for the Treatment of Obesity in Adults: NICE Technology Appraisal Guidance London NICEGoogle Scholar
National Institute, for Clinical Excellence (2002a) Guidance on the Use of Sibutramine for the Treatment of Obesity in Adults. NICE Technology Appraisal Guidance London NICEGoogle Scholar
National Institute, for Clinical Excellence (2002b) Full Guidance on the Use of Surgery to Aid Weight Reduction for People with Morbid Obesity. NICE Technology Appraisal Guidance London NICEGoogle Scholar
Peeters, A, Barendregt, JJ, Willekens, F, Mackenbach, JP, Al, Mamun, A Bonneux, L (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Annals of Internal Medicine 138, 24–32 CrossRefGoogle ScholarPubMed
Prentice, AM & Jebb, SA (1995) Obesity in Britain: gluttony or sloth. British Medical Journal 311, 437–439 Google Scholar
Puska, P, Tuomilehto, J, Nissinen, A & Vartiainen, E (1995) The North Karelia Project. 20 Year Results and Experiences Helsinki, Finland: National Public Health Institute.Google Scholar
Rissanen, AM, Heliovaara, M, Knekt, P, Reunanen, A & Aromaa, A (1991) Determinants of weight gain and overweight in adult Finns. European Journal of Clinical Nutrition 45, 419–430 Google Scholar
Royal College, of Physicians, Royal College, of Paediatrics and, Child Health and, the Faculty, of Public Health (2004) Storing up Problems: The Medical Case for a Slimmer Nation London Royal College of PhysiciansGoogle Scholar
Sever, P (2003) Therapeutic intervention to prevent coronary heart disease and stroke. In Horizons in Medicine, Vol. 15, pp. 263–272 [Weber, J, editors]. London: Royal College of Physicians.Google Scholar
Sjostrom, CD, Peltonen, M & Sjostrom, L (2002) Effects of 2 and 10 years weight loss retention on cardiovascular risk factors. International Journal of Obesity 26, S231 Suppl. 1.Google Scholar
Sjostrom, CD, Peltonen, M, Wedel, H & Sjostrom, L (2000) Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36, 20–25 Google Scholar
Sjostrom, L (2001) Swedish obese subjects, SOS. In International Textbook of Obesity, pp. 519–533 [Bjorntorp, P, editor]. Chichester, West Sussex: John Wiley & Sons.Google Scholar
Sjostrom, L, Despres, J-P & Alain, G (2004) Weight loss in overweight/obese dyslipidemia subjects treated with Rimonabant: the RIO-Lipids Trial. International Journal of Obesity 28, S28 Suppl. 1.Google Scholar
Torgerson, JS, Hauptman, J, Boldrin, MN & Sjostrom, L (2004) Xenical in the prevention of diabetes in obese subjects (XENDOS) study: randomised study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27, 155–161 Google Scholar
Tuomilehto, J, Lindstrom, J, Eriksson, JG, Valle, TT, Hamalainen, H, Ilanne-Parikka, P, Keinanen-Kiukaanniemi, S, Laakso, M, Louheranta, A, Rastas, M, Salminen, V & Uusitupa, M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344, 1343–1350 Google Scholar
Young, LR & Nestle, M (2002) The contribution of expanding portion sizes in the US obesity epidemic. American Journal of Public Health 92, 246–249 Google Scholar